fr

EN DE

fr

EN DE

Publications

2075 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2021

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Dahan L

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.

2021

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Anota A

Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review.

2021

Cancers

Virbel G

Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review.

2021

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Charra-Brunaud C

[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial].

2021

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Dossun C

[Evaluation of quality of life: Clinical relevance for patient].

2021

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Rouffiac M

[Extreme hypofractionated radiation therapy for pancreatic cancer].

2021

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Imperiale A

Values of Ga-DOTATOC and Carbidopa-assisted F-DOPA PET/CT for insulinoma localization.

2021

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Le Guyader M

Under-recognized toxicities of cranial irradiation.

2021

Journal of vascular and interventional radiology : JVIR

Autrusseau PA

Freezing Nodal Disease: Local Control following Percutaneous Image-guided Cryoablation of Loco-regional and Distant Lymph Node Oligometastases - A 10-year Single-centre Experience.

2021

Gut

Oster P

infection has a detrimental impact on the efficacy of cancer immunotherapies.